Skip to Main content Skip to Navigation
New interface
Journal articles

Inhibition of the pseudokinase MLKL alters extracellular vesicle release and reduces tumor growth in glioblastoma

Abstract : Extracellular vesicles (EVs) are lipid-based nanosized particles that convey biological material from donor to recipient cells. EVs play key roles in glioblastoma progression because glioblastoma stem-like cells (GSCs) release pro-oncogenic, proangiogenic, and pro inflammatory EVs. However, the molecular basis of EV release remains poorly understood. Here, we report the identification of the pseudokinase MLKL, a crucial effector of cell death by necroptosis, as a regulator of the constitutive secretion of EVs in GSCs. We find that genetic, protein, and pharmacological targeting of MLKL alters intracellular trafficking and EV release, and reduces GSC expansion. Nevertheless, this function ascribed to MLKL appears independent of its role during necroptosis. In vivo, pharmacological inhibition of MLKL reduces the tumor burden and the level of plasmatic EVs. This work highlights the necroptosis-independent role of MLKL in vesicle release and suggests that interfering with EVs is a promising therapeutic option to sensitize glioblastoma cells.
Document type :
Journal articles
Complete list of metadata

https://www.hal.inserm.fr/inserm-03787564
Contributor : Julie Gavard Connect in order to contact the contributor
Submitted on : Sunday, September 25, 2022 - 5:34:24 PM
Last modification on : Monday, December 5, 2022 - 2:44:08 PM

File

1-s2.0-S2589004222013906-main....
Publication funded by an institution

Identifiers

Citation

Gwennan André-Grégoire, Clément Maghe, Tiphaine Douanne, Sara Rosińska, Fiorella Spinelli, et al.. Inhibition of the pseudokinase MLKL alters extracellular vesicle release and reduces tumor growth in glioblastoma. iScience, 2022, 25, pp.105118. ⟨10.1016/j.isci.2022.105118⟩. ⟨inserm-03787564⟩

Share

Metrics

Record views

38

Files downloads

4